Embecta Corp., (EMBC): Price and Financial Metrics

Embecta Corp., (EMBC): $10.24

0.35 (-3.31%)

POWR Rating

Component Grades








EMBC Price/Volume Stats

Current price $10.24 52-week high $32.00
Prev. close $10.59 52-week low $9.93
Day low $10.22 Volume 16,763
Day high $10.51 Avg. volume 408,830
50-day MA $13.66 Dividend yield 5.85%
200-day MA $16.62 Market Cap 589.61M

EMBC Stock Price Chart Interactive Chart >

Embecta Corp., (EMBC) Company Bio

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.

EMBC Latest News Stream

Event/Time News Detail
Loading, please wait...

EMBC Latest Social Stream

Loading social stream, please wait...

View Full EMBC Social Stream

Latest EMBC News From Around the Web

Below are the latest news stories about EMBECTA CORP that investors may wish to consider to help them evaluate EMBC as an investment opportunity.

Zacks Investment Ideas feature highlights: Beacon Roofing Supply, Embecta and Western Midstream Partners

Beacon Roofing Supply, Embecta and Western Midstream Partners have been highlighted in this Investment Ideas article.

Yahoo | December 21, 2023

Time to Buy These Intriguing Additions to Zacks Rank #1 (Strong Buy) List

Several intriguing stocks were recently added to the Zacks Rank #1 (Strong Buy) list this week and shouldn't be overlooked as we round out what has been an exciting year for the stock market.

Yahoo | December 20, 2023

embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

PARSIPPANY, N.J., Dec. 14, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will present at the J.P. Morgan Healthcare Conference in San Francisco on Wednesday, January 10, 2024 at 2:15 p.m. PT / 5:15 p.m. ET. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company's investor relations website at investors.embecta.com. About embecta embecta is a global diabetes care company that is leveraging its nearl

Yahoo | December 14, 2023

No embecta-made syringes impacted by FDA safety communication

PARSIPPANY, N.J., Dec. 01, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company, today issued the following statement regarding the U.S. Food and Drug Administration (FDA) Safety Communication on evaluation of certain plastic syringes: “embecta, the world’s largest manufacturer of plastic insulin syringes, manufactures all of our syringes distributed worldwide at our facility in Holdrege, Nebraska,” said Shaun Curtis, SVP, Global Manufacturing & Suppl

Yahoo | December 1, 2023

Embecta Corp's Dividend Analysis

Embecta Corp(NASDAQ:EMBC) recently announced a dividend of $0.15 per share, payable on 2023-12-15, with the ex-dividend date set for 2023-12-01. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Embecta Corps dividend performance and assess its sustainability.

Yahoo | December 1, 2023

Read More 'EMBC' Stories Here

EMBC Price Returns

1-mo -22.60%
3-mo -38.34%
6-mo -31.91%
1-year -62.67%
3-year N/A
5-year N/A
YTD -45.34%
2023 -23.12%
2022 N/A
2021 N/A
2020 N/A
2019 N/A

EMBC Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full EMBC Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!